iifl-logo

LIC MF Healthcare Fund Direct G

LIC MF Healthcare Fund Direct G

Fund Name

LIC Mutual Fund

Scheme Name

LIC MF Healthcare Fund Direct G

AMC

LIC Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

08-Feb-2019

Fund Manager

Karan Doshi

Net Assets (Rs. cr)

84.18

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

LIC MF Healthcare Fund Direct G - Nav Details

Nav Date

:  06-Jun-2025

NAV [Rs.]

:  31.1393

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.

LIC MF Healthcare Fund Direct G- NAV Chart

LIC MF Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.59
1.12
6.48
-7.02
19.23
21.55
18.31
19.73
Category Avg
0.64
1.74
8.92
-3.8
19.89
24.84
22.23
17.69
Category Best
1.32
5.25
15.13
-0.14
30.95
29.5
26.01
36.02
Category Worst
-0.06
-0.33
4.57
-8.85
11.81
20.12
16.87
-4.96

LIC MF Healthcare Fund Direct G- Latest Dividends

No Records Found

LIC MF Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

500

In & Out

In

InName Of The CompanyNo Of Shares
Linde India1,758

Out

InName Of The CompanyNo Of Shares
Laurus Labs25,578

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.73538519.03
EquityCiplaPharmaceuticals & Biotechnology5.43312184.57
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.95131304.16
EquityDivi's Lab.Pharmaceuticals & Biotechnology4.8461584.07
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.27313013.59
EquityPiramal PharmaPharmaceuticals & Biotechnology4.221721113.55
EquityNeuland Labs.Pharmaceuticals & Biotechnology4.1130113.46
EquityFortis Health.Healthcare Services4.00477143.37
EquityAlkem LabPharmaceuticals & Biotechnology3.7662123.16
EquityArtemis MedicareHealthcare Services3.611088323.04
EquityAbbott IndiaPharmaceuticals & Biotechnology3.509682.94
EquityApollo HospitalsHealthcare Services3.4842642.93
EquityVinati OrganicsChemicals & Petrochemicals3.37154042.83
EquityNavin Fluo.Intl.Chemicals & Petrochemicals3.3666362.82
EquityIpca Labs.Pharmaceuticals & Biotechnology3.10183112.60
EquitySyngene Intl.Healthcare Services3.02393722.54
EquityJ B Chemicals &Pharmaceuticals & Biotechnology2.94147522.47
EquityConcord BiotechPharmaceuticals & Biotechnology2.56123412.15
EquityMankind PharmaPharmaceuticals & Biotechnology2.5185772.11
EquityDr Agarwal's HeaHealthcare Services2.42603092.04
EquityMetropolis HealtHealthcare Services2.28114171.91
EquityMax HealthcareHealthcare Services2.24167751.88
EquityGlobal HealthHealthcare Services2.11149521.77
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology2.10121501.77
EquityCohance LifePharmaceuticals & Biotechnology1.68135051.41
EquityOneSource Speci.Pharmaceuticals & Biotechnology1.6773321.40
EquityZydus Lifesci.Pharmaceuticals & Biotechnology1.67151391.40
EquityLinde IndiaChemicals & Petrochemicals1.5717581.31
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.0917400.91
Cash & Cash Equivalent
Reverse RepoTREPS-/-4.3303.64
Net CA & OthersNet CA & Others-/--0.950-0.79

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
36,564.37
Trustee/s:
LIC Mutual Fund Trustee P, Mr. Pradeep Jagannath Bhi, Mr. Rammohan Nilkanth Bha
Chairman:
NA
CEO / MD:
Ravi Kumar Jha, T.S. Ramakrishnan
CIO:
NA
President:
NA
Director/s:
Sanjay Achyutrao Muthal, Praveen Garg, Raghunandan Maluste, Vijay Sharma, Siddhartha Mohanty
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP

OTHER INFORMATION

Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.